Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report)’s stock price traded up 77.5% during trading on Thursday . The company traded as high as $2.84 and last traded at $2.84. 59,306 shares traded hands during mid-day trading, an increase of 2,761% from the average session volume of 2,073 shares. The stock had previously closed at $1.60.
Talis Biomedical Price Performance
The stock has a market capitalization of $5.18 million, a PE ratio of -0.10 and a beta of 1.32. The company has a 50-day moving average of $1.65 and a two-hundred day moving average of $1.53.
About Talis Biomedical
Talis Biomedical Corp is a molecular diagnostics company that develops point-of-care testing solutions for infectious diseases. The company’s technology leverages sample-to-answer automation to deliver rapid, lab-quality results outside of traditional laboratory settings. Talis Biomedical focuses on simplifying complex molecular assays to enable broader access in clinical laboratories, urgent care facilities and other decentralized testing environments.
The company’s flagship Talis One platform integrates proprietary reagents, single-use test cartridges and a compact analyzer to automate the workflow from extracted sample to result.
See Also
- Five stocks we like better than Talis Biomedical
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- What Are Growth Stocks and Investing in Them
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- What Are Dividends? Buy the Best Dividend Stocks
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
Receive News & Ratings for Talis Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talis Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
